Depressive symptoms in neurodegenerative diseases

被引:116
|
作者
Baquero, Miquel [1 ]
Martin, Nuria [1 ]
机构
[1] Hosp Univ & Politecn La Fe, Serv Neurol, Avinguda F Abril Martorell,106, Valencia 46026, Spain
关键词
Neurodegenerative diseases; Alzheimer; Depressive symptoms; Frontotemporal degeneration; Vascular dementia; Lewy body disease; Depression; Dementia; MILD COGNITIVE IMPAIRMENT; PROVISIONAL DIAGNOSTIC-CRITERIA; LATE-LIFE DEPRESSION; BRIEF CLINICAL FORM; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NEUROPSYCHIATRIC INVENTORY; FRONTOTEMPORAL DEMENTIA; VASCULAR DEMENTIA; LEWY BODIES;
D O I
10.12998/wjcc.v3.i8.682
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depressive symptoms are very common in chronic conditions. This is true so for neurodegenerative diseases. A number of patients with cognitive decline and dementia due to Alzheimer's disease and related conditions like Parkinson's disease, Lewy body disease, vascular dementia, frontotemporal degeneration amongst other entities, experience depressive symptoms in greater or lesser grade at some point during the course of the illness. Depressive symptoms have a particular significance in neurological disorders, specially in neurodegenerative diseases, because brain, mind, behavior and mood relationship. A number of patients may develop depressive symptoms in early stages of the neurologic disease, occurring without clear presence of cognitive decline with only mild cognitive deterioration. Classically, depression constitutes a reliable diagnostic challenge in this setting. However, actually we can recognize and evaluate depressive, cognitive or motor symptoms of neurodegenerative disease in order to establish their clinical significance and to plan some therapeutic strategies. Depressive symptoms can appear also lately, when the neurodegenerative disease is fully developed. The presence of depression and other neuropsychiatric symptoms have a negative impact on the quality-of-life of patients and caregivers. Besides, patients with depressive symptoms also tend to further decrease function and reduce cognitive abilities and also uses to present more affected clinical status, compared with patients without depression. Depressive symptoms are treatable. Early detection of depressive symptoms is very important in patients with neurodegenerative disorders, in order to initiate the most adequate treatment. We review in this paper the main neurodegenerative diseases, focusing in depressive symptoms of each other entities and current recommendations of management and treatment.
引用
收藏
页码:682 / 693
页数:12
相关论文
共 50 条
  • [1] Depressive symptoms in neurodegenerative diseases
    Miquel Baquero
    Nuria Martín
    World Journal of Clinical Cases, 2015, (08) : 682 - 693
  • [2] Neurodegenerative diseases, suicide and depressive symptoms in relation to EMF
    Ahlbom, A
    BIOELECTROMAGNETICS, 2001, : S132 - S143
  • [3] Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review
    Seritan, Andreea L.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2023, 36 (06) : 435 - 460
  • [4] Neurodegenerative diseases
    Reith, Wolfgang
    RADIOLOGE, 2018, 58 (03): : 241 - 258
  • [5] Neurochemical correlation between major depressive disorder and neurodegenerative diseases
    Reus, Gislaine Z.
    Titus, Stephanie E.
    Abelaira, Helena M.
    Freitas, Sharon M.
    Tuon, Talita
    Quevedo, Joao
    Budni, Josiane
    LIFE SCIENCES, 2016, 158 : 121 - 129
  • [6] Neuropsychiatric symptoms and creativity in neurodegenerative diseases
    Nikolai, Tomas
    Kuska, Martin
    Trnka, Radek
    CESKOSLOVENSKA PSYCHOLOGIE, 2020, 64 (05): : 564 - 577
  • [7] Hallucinations in Neurodegenerative Diseases
    Burghaus, Lothar
    Eggers, Carsten
    Timmermann, Lars
    Fink, Gereon R.
    Diederich, Nico J.
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (02) : 149 - 159
  • [8] The role of hand preference in cognition and neuropsychiatric symptoms in neurodegenerative diseases
    Saari, Toni T.
    Vuoksimaa, Eero
    BRAIN COMMUNICATIONS, 2023, 5 (03)
  • [9] White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
    Ozzoude, Miracle
    Varriano, Brenda
    Beaton, Derek
    Ramirez, Joel
    Adamo, Sabrina
    Holmes, Melissa
    Scott, Christopher J. M.
    Gao, Fuqiang
    Sunderland, Kelly
    McLaughlin, Paula
    Goubran, Maged
    Kwan, Donna
    Roberts, Angela
    Bartha, Robert
    Symons, Sean
    Tan, Brian
    Swartz, Richard
    Abrahao, Agessandro
    Saposnik, Gustavo
    Masellis, Mario
    Lang, Anthony
    Marras, Connie
    Zinman, Lorne
    Shoesmith, Christen
    Borrie, Michael
    Fischer, Corinne
    Frank, Andrew
    Freedman, Morris
    Montero-Odasso, Manuel
    Kumar, Sanjeev
    Pasternak, Stephen
    Strother, Stephen
    Pollock, Bruce
    Rajji, Tarek
    Seitz, Dallas
    Tang-Wai, David
    Turnbull, John
    Dowlatshahi, Dar
    Hassan, Ayman
    Casaubon, Leanne
    Mandzia, Jennifer
    Sahlas, Demetrios
    Breen, David A.
    Grimes, David
    Jog, Mandar
    Steeves, Thomas D. L.
    Arnott, Stephen
    Black, Sandra
    Finger, Elizabeth
    Rabin, Jennifer
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [10] Typical Cerebral Metabolic Patterns in Neurodegenerative Brain Diseases
    Teune, Laura K.
    Bartels, Anna L.
    de Jong, Bauke M.
    Willemsen, Antoon T. M.
    Eshuis, Silvia A.
    de Vries, Jeroen J.
    van Oostrom, Joost C. H.
    Leenders, Klaus L.
    MOVEMENT DISORDERS, 2010, 25 (14) : 2395 - 2404